caspofungin vs tacrolimus topical
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of caspofungin and tacrolimus topical. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
minor Known Drug Interaction
Caspofungin May decrease tacrolimus whole blood trough concentrations.
Cancidas
Protopic
Caspofungin is an antifungal medicine. It fights fungal infections in your body.
Tacrolimus extended-release capsules help prevent organ rejection in kidney transplant patients. It works by suppressing your immune system.
Caspofungin treats several types of fungal infections. It is used for presumed fungal infections in patients with fever and low white blood cell counts. Caspofungin also treats infections caused by Candida, such as infections in the blood, abdomen, and esophagus. It can also treat invasive aspergillosis when other medicines don't work or can't be tolerated.
This medicine is used to prevent your body from rejecting a new kidney after a transplant. It is for adult patients who can swallow capsules whole. You will take it with other medicines that also suppress your immune system.
Caspofungin stops fungi from growing. It does this by blocking a key part of the fungal cell wall. This causes the fungal cells to die.
Tacrolimus belongs to a class of drugs called calcineurin inhibitors. It lowers the activity of your immune system. This helps prevent your body from attacking your new kidney.
- • Diarrhea
- • Fever
- • Increased liver enzyme levels
- • Decreased potassium levels
- • Rash
- • Diarrhea
- • Constipation
- • Nausea
- • Swelling in your arms and legs
- • Tremors
- Death 223
- Lung infection 200
- Fever 196
- Blood infection 193
- Severe blood infection leading to organ damage 175
No adverse event reports.
Caspofungin can cause serious allergic reactions, including anaphylaxis. If you have signs of an allergic reaction, stop taking caspofungin right away. Caspofungin can also affect your liver. Your doctor will monitor your liver function with blood tests.
This medicine can increase your risk of serious infections and certain cancers. These problems could lead to hospitalization or even death. This drug is not approved for liver transplants and may increase the risk of death in female liver transplant patients.
Caspofungin may harm your unborn baby. Tell your doctor if you are pregnant or plan to become pregnant. It is not known if caspofungin passes into breast milk, so talk to your doctor about breastfeeding while taking this medicine.
Tacrolimus can harm your unborn baby. Tell your doctor right away if you are pregnant or plan to become pregnant. There is a pregnancy registry to track outcomes in women who take tacrolimus during pregnancy.
Also Compare, Nearby Drugs
Compare caspofungin with
Compare tacrolimus topical with
How to Read This caspofungin vs tacrolimus topical Comparison
caspofungin is classified in the Echinocandin Antifungal drug class, while tacrolimus topical sits within the Calcineurin Inhibitor (Topical) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, caspofungin has 987 submissions while tacrolimus topical has 0. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to caspofungin can cause your body to clear tacrolimus more quickly, resulting in lower levels of the drug in your bloodstream.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for caspofungin or tacrolimus topical.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.